Hospital Sotero del Rio
Santiago, Santiago Metropolitan, 8207257, Chile
Location status: Recruiting
Location contact
Erik Manriquez Alegria, MD
CONTACT
Felipe Quezada Diaz, MD
CONTACT
NCT Number: NCT07740122
This prospective observational substudy evaluates the association between artificial intelligence-derived features from stool images analyzed using the FAEX Health digital platform and fecal immunochemical test results in adults undergoing colorectal cancer screening or diagnostic evaluation. Participants will capture stool images using a mobile application. The primary analysis will compare AI-derived image outputs with quantitative FIT values and FIT positivity. Secondary exploratory analyses will assess associations with colonoscopy and histopathological findings when these results are available. The platform will be used exclusively for research and will not provide diagnoses, replace clinical evaluation, or influence medical decisions.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Santiago, Santiago Metropolitan, 8207257, Chile
Location status: Recruiting
Erik Manriquez Alegria, MD
CONTACT
Felipe Quezada Diaz, MD
CONTACT
This is a substudy of the project "Estrategia de prevención secundaria de cáncer colorrectal en personas mayores a 18 años." The substudy evaluates the FAEX Health digital platform, which applies artificial intelligence algorithms to stool images for non-diagnostic research and validation.
Participants will capture images of their stools using the FAEX Health mobile application. The images will be coded and analyzed using computational algorithms designed to identify visual characteristics such as color, consistency, and possible visible blood.
The primary objective is to evaluate the association and discriminatory performance of AI-derived stool image features for quantitative fecal immunochemical test results and FIT positivity. Secondary exploratory objectives are to assess associations between these image features and colonoscopic and histopathological findings among participants for whom these results are available.
The AI-derived results will not be returned to participants or treating clinicians and will not be used to determine whether colonoscopy or any other clinical procedure is performed. The findings may inform future studies evaluating stool image analysis as a potential triage strategy when FIT is unavailable or declined; however, the present study does not evaluate the platform as a replacement for FIT.
Personal identifiers will not be stored together with stool images. Access to coded study information will be restricted to authorized researchers, and study data will be managed according to applicable ethical, legal, and confidentiality requirements.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants capture stool images using the FAEX Health mobile application. Coded images are analyzed using artificial intelligence algorithms to derive visual features and a prespecified patient-level output or score. The AI-derived output is used exclusively for research and is compared primarily with quantitative FIT results and FIT positivity, with secondary comparisons against colonoscopy and histopathology when available. The output is not used to provide a diagnosis or guide clinical management.
Time frame: Within 90 days of stool image submission
Correlation coefficient between the prespecified patient-level AI-derived stool image score and quantitative fecal immunochemical test concentration among participants with analyzable matched data, reported with a 95% confidence interval.
Time frame: Within 90 days of stool image submission
Area under the receiver operating characteristic curve of the prespecified AI-derived stool image score for classifying participants as FIT positive or FIT negative according to the locally established FIT threshold, reported with a 95% confidence interval.
Time frame: Within 90 days of stool image submission
Sensitivity and Specificity of a prespecified AI-derived stool image score threshold for identifying participants with a positive/negative FIT result, reported as a percentage with a 95% confidence interval.
Time frame: Within 90 days of stool image submission
Area under the receiver operating characteristic curve of the AI-derived stool image score for identifying colorectal neoplasia detected at colonoscopy, with histopathological confirmation when available.
Contact information is provided by the study sponsor or research team.
Erik Manriquez Alegria, MD
CONTACT
Felipe Quezada Diaz, MD
CONTACT
Servicio de Salud Metropolitano Sur Oriente
Other Gov
FECAL-AI: Prospective Observational Validation of AI-Based Stool Image Analysis Against Quantitative Fecal Immunochemical Testing for Colorectal Neoplasia Risk Assessment
Acronym: FECAL-AI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06750094
Colonic Diseases, Colorectal Neoplasms
Chandler, Arizona, United States
View Trial DetailsNCT06662786
Colonic Diseases, Colorectal Neoplasms
Gilbert, Arizona, United States
View Trial DetailsNCT04222413
Advanced Breast Cancer, Advanced Solid Tumors
Fairway, Kansas, United States
View Trial DetailsNCT01915225
Adenocarcinoma, Bile Duct Cancer
Bethesda, Maryland, United States
View Trial Details